title: In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep.
abstract: Oligodeoxynucleotides (ODN) containing cytosine-phosphate-guanosine (CpG) motifs have been shown to activate the innate immune system and protect mice and chicken from bacterial and viral infections. Unfortunately, similar studies in other veterinary species are lacking. In this study we assessed the in vivo immunostimulatory effects of CpG ODN 2007, an ODN with previously demonstrated in vitro biological activity. The in vivo effects of ODN 2007 were compared in two closely related outbred species, sheep and cattle, to determine if there were common biological responses. We demonstrated that subcutaneous (s.c.) injection of the CpG ODN induces an acute phase response in the form of a transient fever, a mild transient increase in circulating neutrophils and elevated serum haptoglobin in both sheep and cattle. Sheep injected with CpG ODN also exhibited increased serum 2'5'-oligoadenylate (2'5'-A) synthetase activity, but no increase in serum 2'5'-A synthetase was detected in cattle. The ODN-induced responses were stronger in animals injected with CpG ODN formulated in 30% emulsigen than phosphate buffer saline (PBS) alone. These in vivo data demonstrate for the first time that a CpG ODN induces acute phase immunostimulatory responses in sheep and cattle. However, CpG ODN-induced antiviral effector molecule 2'5'-A synthetase was detected only in sheep but not in cattle.
authors.affiliation: Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan, Canada S7N 5E3.
authors.forename: A K
authors.initials: AK
authors.lastname: Nichani
authors.forename: A
authors.initials: A
authors.lastname: Mena
authors.forename: Y
authors.initials: Y
authors.lastname: Popowych
authors.forename: D
authors.initials: D
authors.lastname: Dent
authors.forename: H G G
authors.initials: HG
authors.lastname: Townsend
authors.forename: G K
authors.initials: GK
authors.lastname: Mutwiri
authors.forename: R
authors.initials: R
authors.lastname: Hecker
authors.forename: L A
authors.initials: LA
authors.lastname: Babiuk
authors.forename: P J
authors.initials: PJ
authors.lastname: Griebel
mesh_terms: D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood; D000210:Acute-Phase Reaction; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000911:Antibodies, Monoclonal; D002417:Cattle / Q000276:immunology*; D005260:Female; D005334:Fever / Q000209:etiology / Q000276:immunology; D006242:Haptoglobins / Q000276:immunology; D007113:Immunity, Innate; D007958:Leukocyte Count; D008297:Male; D009504:Neutrophils; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000494:pharmacology*; D012756:Sheep / Q000276:immunology*; D013045:Species Specificity
chemical_list: D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; C408982:CPG-oligonucleotide; D006242:Haptoglobins; D009838:Oligodeoxyribonucleotides; D015088:2',5'-Oligoadenylate Synthetase